Local, national & international business news and events.
Broadens Merck Animal Health’s Position with Enhanced Parasite Protection in Calves and Lambs MADISON, N.J.–(BUSINESS WIRE)–$MRK #AnimalHealth–Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today
Reopened Over 200 Stores To-Date in Phased Approach Reduction in Force Implemented to Help Offset Impact of Reduced Traveler Volumes EAST RUTHERFORD, N.J.–(BUSINESS WIRE)–Hudson (NYSE: HUD), a North American travel experience leader with more than 1,000 stores in airports, commuter hubs, landmarks
SOMERSET, N.J.–(BUSINESS WIRE)–SHI International, one of North America’s largest IT solutions providers, has been recognized on Forbes’ list of America’s Best Employers for Women 2020. Presented by Forbes and Statista Inc., the awards list is based on an independent survey of over
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has assigned a Long-Term Issuer Credit Rating of “a” to LRG (US), Inc. (Delaware). The outlook assigned to this Credit Rating (rating) is stable. LRG (US), Inc. is the intermediate holding company of London Life International Reinsurance Corporation
2020 Second Quarter Results Sales growth +10.6%: Dom. +13.6%; Int’l +0.5%; SPD +3.0% Organic sales +8.4%: Dom. +10.7%; Int’l +0.6%; SPD +3.0% Gross Margin +220 bps. to 46.8% EPS +36.4%; Adjusted EPS +35.1% YTD Cash from Operations +70%; Ex tax deferral +47%
Leading cloud software company for insurance carriers improves organizational productivity and increases employee engagement MORRISTOWN, N.J.–(BUSINESS WIRE)–Majesco, a global leader of cloud insurance software, today announced the implementation of Oracle Cloud HCM to help meet its long-term strategic and operational goals. With
— Net Cash Provided by Operating Activities Increased to $246.4 Million for the First Two Quarters of 2020 — PARSIPPANY, N.J.–(BUSINESS WIRE)–B&G Foods, Inc. (NYSE: BGS) today announced financial results for the second quarter and first two quarters of 2020 and provided
Japan Business Venture shifts focus to specialty assets and a portfolio of select generics that meet patients’ medical needs Remains positioned to address unmet patient needs in core therapeutic areas Will divest majority of current non-differentiated generics portfolio, as well as local
BLA submission based on results from pivotal Phase 2 KarMMa study evaluating ide-cel in heavily pre-treated patient population Companies are committed to working with the FDA to rapidly advance ide-cel through the regulatory review process PRINCETON, N.J., & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$BLUE #BMS—Bristol